Micron Technology, Inc. (NASDAQ:MU) is one of the best cheap stocks to buy for beginners. On June 3, Morgan Stanley lifted the price target on Micron Technology, Inc. (NASDAQ:MU) to $1,050 from $520, maintaining an Overweight rating on the shares and stating that there is “no quick fix to the memory shortage” that is going to […]
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Over the last six months, Enovis’s shares have sunk to $22.66, producing a disappointing 16.1% loss - a stark contrast to the S&P 500’s 10% gain. This might have investors contemplating their next move.
Over the past six months, Integra LifeSciences has been a great trade, beating the S&P 500 by 25.3%. Its stock price has climbed to $17.91, representing a healthy 35.3% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
AI investors who missed the high-bandwidth memory boom may have a second chance as silicon photonics becomes the next critical bottleneck in AI infrastructure.
Hilton Grand Vacations’s 17.5% return over the past six months has outpaced the S&P 500 by 7.5%, and its stock price has climbed to $49.76 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
It's time for investors to buy some best-in-class beaten-down tech stocks that aren't related to AI, as Wall Street finally starts taking profits on soaring AI and chip stocks.
Amazon (NASDAQ:AMZN) is a stock worth owning for decades because the cash engines underneath the retail storefront, AWS, advertising, and Prime, throw off compounding profits no single recession or product cycle can break. For a retirement-focused investor who has been burned chasing trends, the case here rests on the boring math of a business whose ... History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now
Strategy Inc. (NASDAQ:MSTR) is one of the most undervalued large cap stocks to buy according to analysts. On May 26, Strategy completed a series of capital-markets and bitcoin transactions between May 11 and May 25, aimed at optimizing its balance sheet. Key actions included the repurchase of $1.5 billion in 2029 convertible notes at an […]
The nuclear resurgence is here, and power-hungry data centers could provide a strong tailwind for the industry going forward.
Opendoor Technologies (NASDAQ:OPEN) is once again lighting up retail trading screens after a 588.38% one-year run that has turned a former penny stock into the housing trade of choice on r/wallstreetbets. The iBuyer Math No Longer Works High borrowing costs are freezing residential transaction volume, and the low-margin iBuying model cannot survive a stalled housing ... Forget Opendoor Technologies: Buy This High-Yield Real Estate Monopoly Instead
By Lewis Krauskopf NEW YORK, June 5 (Reuters) - The long-awaited, massive SpaceX initial public offering is expected next week, a major event for the U.S. stock market, with investors wary of possible
Microsoft is looking to become a more significant player in artificial intelligence.
After a brutal stretch, the insurance behemoth came roaring back. But does the underlying data fully support the sustainability of this momentum.
Sandisk has taken investors on quite the rocketship ride.
If you are wondering whether Uranium Energy's share price still offers value after a strong run, the key is to look past the headlines and focus on what the current valuation is really telling you. The stock last closed at US$14.14, with returns of 4.4% over the past week, a decline of 2.5% over the past month, 7.9% year to date and 131.0% over the last year, plus very large gains over 3 and 5 years of around 3.5x. These moves have come alongside ongoing interest in uranium related companies...
Recent performance snapshot Hut 8 (HUT) has caught investor attention after a sharp move in the stock over the past month, with the price up about 59% and recent daily trading showing noticeable swings. See our latest analysis for Hut 8. Zooming out from the sharp 58.69% 30 day share price return, Hut 8’s 171.43% 90 day share price return and very large 1 year total shareholder return indicate that the stock has shown strong recent momentum. If you are looking beyond Hut 8 and want to see...
Earnings growth hasn't been this strong in years. But some valuation measures are near all-time highs. Which narrative should investors choose?
In early June 2026, Biogen reported that the FDA granted Breakthrough Therapy Designation to its investigational SMA treatment salanersen, while also, alongside UCB, presenting additional positive Phase 3 data for lupus candidate dapirolizumab pegol at the EULAR 2026 Congress. Together, these developments highlight Biogen’s expanding late-stage pipeline in severe neuromuscular and autoimmune diseases, with salanersen’s once-yearly dosing and dapirolizumab pegol’s steroid-sparing potential...
POET Technologies (NASDAQ:POET) trades at $13.89 as of June 2, 2026. Our 24/7 Wall St. price target for POET is $10.41 over the next 12 months, implying 25% downside from current levels. Our recommendation is sell with moderate confidence of 50%, reflecting mixed signals between bullish analyst sentiment and a stretched price after a sharp ... Prediction: Poet’s 220% Surge Sets Up a Potential Correction
Palo Alto stock fell after its fiscal Q3 report, but the stock has seen huge gains over the past few months.
The inflation fears sparking Friday's selloff propelled the 2-year Treasury yield to its level since Feb. 2025. The 2-year note settled at 4.160%, while the 10-year Treasury yield rose to 4.537%. Investors dumped bonds after a hot jobs report rekindled the possibility of rate hikes this year.
Rigetti Computing (NASDAQ:RGTI) is back in every quantum chat room after running 53.6% in a month on hopes that its 108-qubit system finally turns research into revenue. But here’s what you should actually be watching. The Rigetti story sounds great until you read the income statement. Full-year 2025 revenue declined to $7.09 million from $10.79 ... Forget This Cash-Burning Quantum Speculation and Buy the Stock With a Real Enterprise Backlog
Few stocks have rewarded believers like Rocket Lab (NASDAQ:RKLB) over the past 12 months. The shares have climbed 356.85% in a year, and the company just posted its first ever $200 million revenue quarter. The question now is whether the price has gotten ahead of the fundamentals. The stock trades at $122.39. Our 24/7 Wall ... We’re Holding Rocket Lab Despite 356% Rally
Friday’s carnage in tech stocks shows just how fragile this year’s rally has become. Then came an unexpectedly good jobs report for May. A healthier labor market could lead the Federal Reserve to keep interest rates elevated to combat inflation. Indeed, investors on Friday were pricing in an around 50% chance that the Fed could hike in October, up from a less than 20% chance a month ago.
Income investors have piled into Verizon Communications (NYSE:VZ) this year, sending the stock up 21.4% year to date as the crowd chases a 5.78% dividend yield and the company’s old “premium network” reputation. But here’s what you should actually be watching. Verizon is the textbook telecom value trap. The stock now carries a $199.3 billion ... Forget Wall Street’s Ultimate Telecom Value Trap and Buy the Real Free Cash Flow King
Biogen (BIIB) is back in focus after the FDA granted Breakthrough Therapy Designation to its spinal muscular atrophy candidate salanersen, while fresh Phase 3 lupus data with partner UCB highlighted dapirolizumab pegol’s clinical profile. See our latest analysis for Biogen. Biogen’s recent FDA breakthrough designation for salanersen and fresh lupus data arrive as the share price trades at US$196.45, with a 90-day share price return of 6.26% and a 1-year total shareholder return of 50.70%,...
With the S&P 500 grinding near record highs, sub-$30 stocks have become hunting grounds for income investors who want yield without paying a premium. A low sticker price is only meaningful when the underlying business supports it, and a household-name industrial throwing off a mid-single-digit dividend yield while trading at a single-digit forward earnings multiple ... 1 High-Yield Dividend Stock Under $30 to Buy Hand Over Fist and Hold Forever
Apple (NASDAQ:AAPL) just hit a fresh all-time high, and the question on every shareholder’s mind is whether the run has legs into year-end. Our model says yes, with some moderation. The stock closed at $315.20 on June 2, 2026, up 2.9% on the day and 16.16% year to date. Our 24/7 Wall St. price target ... Apple Stock Nears All-Time High: Where Will It End The Year?